Cytokinetics (CYTK) Current Leases (2019 - 2025)
Historic Current Leases for Cytokinetics (CYTK) over the last 6 years, with Q3 2024 value amounting to $18.9 million.
- Cytokinetics' Current Leases rose 939.89% to $18.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $18.9 million, marking a year-over-year increase of 939.89%. This contributed to the annual value of $17.9 million for FY2023, which is 3945.75% up from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Current Leases is $18.9 million, which was up 939.89% from $18.5 million recorded in Q2 2024.
- Cytokinetics' Current Leases' 5-year high stood at $18.9 million during Q3 2024, with a 5-year trough of $2.8 million in Q4 2020.
- Its 5-year average for Current Leases is $12.7 million, with a median of $14.3 million in 2022.
- Per our database at Business Quant, Cytokinetics' Current Leases crashed by 3966.64% in 2020 and then surged by 43368.04% in 2021.
- Quarter analysis of 5 years shows Cytokinetics' Current Leases stood at $2.8 million in 2020, then surged by 433.68% to $14.9 million in 2021, then decreased by 13.68% to $12.8 million in 2022, then surged by 39.46% to $17.9 million in 2023, then increased by 5.39% to $18.9 million in 2024.
- Its last three reported values are $18.9 million in Q3 2024, $18.5 million for Q2 2024, and $18.2 million during Q1 2024.